DrugDashboards

Sunmark Chest Congestion Relief DM DM

Dextromethorphan Hydrobromide / Guaifenesin · DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1 · Tablet · Oral · Strategic Sourcing Services LLC

NDC 49348-0728-09 · 1 BOTTLE in 1 CARTON / 50 TABLET in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

16 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0796 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Nov 2013Sep 2026$0.0796
146 price points · per EA · held since Invalid DateSource: CMS NADAC

Estimated fill cost

#30 count
$2.39
#90 count
$7.17

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2024)

$162
14 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for dextromethorphan hydrobromide, guaifenesin (oral solid) in the next 90 days

sole-source market · price up 1% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M012
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dextromethorphan Hydrobromide / Guaifenesin (Tablet)

LabelerStrengthFirst seenLast seen
Chain Drug Marketing AssociationDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 3, 2026
Strategic Sourcing Services LLCDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 3, 2026
AmerisourceBergen Drug CorpDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Cardinal HealthDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
CVS Pharmacy, Inc.DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Dolgencorp, LLCDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Family Dollar Services IncDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Marc Glassman IncDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Reese Pharmaceutical CoDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Retail Business Services , LlcDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Rugby LaboratoriesDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
The Kroger CoDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Topco Associates LlcDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
United Natural Foods, Inc. dba UNFIDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026
Valu MerchDEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sunmark Chest Congestion Relief DM DM — NDC 49348-0728-09," retrieved September 3, 2026, https://drugdashboards.com/drug/49348072809.

Free to cite with attribution — see how the data is put together.